Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

Barraco, Nadia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.895
EU - Europa 2.795
AS - Asia 2.249
SA - Sud America 413
AF - Africa 71
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.791
SG - Singapore 920
IT - Italia 836
RU - Federazione Russa 781
CN - Cina 518
DE - Germania 351
BR - Brasile 340
VN - Vietnam 214
HK - Hong Kong 202
FI - Finlandia 181
GB - Regno Unito 132
PL - Polonia 132
FR - Francia 127
IN - India 69
BD - Bangladesh 64
CA - Canada 60
JP - Giappone 60
IE - Irlanda 49
KR - Corea 47
NL - Olanda 38
SE - Svezia 29
MX - Messico 26
TR - Turchia 26
IQ - Iraq 24
ZA - Sudafrica 22
AR - Argentina 21
AT - Austria 21
BE - Belgio 21
ES - Italia 21
UA - Ucraina 19
RO - Romania 15
EC - Ecuador 13
MY - Malesia 13
IR - Iran 11
PK - Pakistan 10
VE - Venezuela 10
AL - Albania 9
EG - Egitto 8
ID - Indonesia 8
MA - Marocco 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CO - Colombia 7
SA - Arabia Saudita 7
UY - Uruguay 7
AZ - Azerbaigian 6
KE - Kenya 6
LT - Lituania 6
PY - Paraguay 6
UZ - Uzbekistan 6
CI - Costa d'Avorio 5
LB - Libano 5
PH - Filippine 5
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
DZ - Algeria 4
HU - Ungheria 4
KZ - Kazakistan 4
NP - Nepal 4
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
AO - Angola 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GT - Guatemala 2
KG - Kirghizistan 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
NI - Nicaragua 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GH - Ghana 1
JO - Giordania 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MQ - Martinica 1
NA - Namibia 1
OM - Oman 1
Totale 10.427
Salva come PNG Salva come JPEG
Città #
Ashburn 686
Singapore 563
Fairfield 444
San Jose 324
Chandler 315
Seattle 201
Houston 192
Hong Kong 188
Wilmington 187
Woodbridge 177
Palermo 176
Moscow 157
Council Bluffs 139
Cambridge 128
New York 118
Helsinki 116
Ann Arbor 112
The Dalles 110
Rome 103
Zgierz 102
Munich 101
Los Angeles 97
Beijing 95
Santa Clara 76
Ho Chi Minh City 71
Medford 61
Hefei 56
Tokyo 56
Boardman 54
Lauterbourg 52
Des Moines 49
Dallas 45
Dublin 45
Hanoi 44
Chicago 42
Milan 42
Frankfurt am Main 41
Princeton 40
Buffalo 38
Ludwigshafen am Rhein 35
Nanjing 35
San Diego 33
Lawrence 32
London 32
Seoul 30
Orem 29
São Paulo 29
Kitzingen 28
Altamura 27
Warsaw 26
Denver 21
Bremen 20
Brussels 19
Montreal 19
Brooklyn 17
Dearborn 17
Phoenix 17
Atlanta 16
Nuremberg 16
Johannesburg 15
Chennai 14
Falls Church 13
Jinan 13
Kumar 13
Lappeenranta 13
Rio de Janeiro 12
Schiffdorf 12
Turin 12
Pune 11
Shenyang 11
Stockholm 11
Tianjin 11
Volla 11
Amsterdam 10
Baghdad 10
Boston 10
Da Nang 10
Guangzhou 10
Haiphong 10
Mexico City 10
Redwood City 10
Belo Horizonte 9
Catania 9
Manchester 9
Milazzo 9
Tappahannock 9
Toronto 9
Tulsa 9
Vienna 9
Bari 8
Falkenstein 8
Florence 8
Hangzhou 8
Mumbai 8
Aversa 7
Bexley 7
Brasília 7
Cairo 7
Elk Grove Village 7
Izmir 7
Totale 6.547
Salva come PNG Salva come JPEG
Nome #
Dietary restriction: could it be considered as speed bump on tumor progression road? 325
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 321
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 319
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 314
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 303
A headlight on liquid biopsies: a challenging tool for breast cancer management 287
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 282
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 267
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 259
Nintedanib in NSCLC: Evidence to date and place in therapy 257
TTF-1/p63-positive poorly differentiated NSCLC: A histogenetic hypothesis from the basal reserve cell of the terminal respiratory unit 255
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 246
LncRNA H19, HOTAIR AND MALAT1 AS MOLECULAR BIOMARKERS IN GIST 244
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 235
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 232
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 230
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 230
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 227
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 224
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 215
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 207
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 202
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 199
Non-coding RNAs functioning in colorectal cancer stem cells 197
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 193
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 182
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 178
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 177
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 176
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 175
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 174
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 171
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups 169
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 168
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 165
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 162
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 160
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 158
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 152
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 149
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 148
Liquid Biopsy in Gastrointestinal Stromal Tumor 147
Cancer of the Thyroid 143
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 142
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible 141
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 140
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier? 140
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 139
Molecular tumor board 138
Current clinically validated applications of liquid biopsy 129
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses 129
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 125
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 109
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 108
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code 101
Future perspectives 77
null 25
Totale 10.867
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022655 79 113 20 20 27 49 34 29 62 57 66 99
2022/2023912 79 143 26 133 88 128 52 92 92 12 39 28
2023/2024592 28 57 36 55 31 116 86 54 16 19 9 85
2024/20251.819 40 122 83 130 89 139 254 171 110 226 212 243
2025/20264.657 429 172 279 446 503 692 667 421 369 297 171 211
2026/202763 63 0 0 0 0 0 0 0 0 0 0 0
Totale 10.867